Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Heart Fail Rep. 2012 Mar;9(1):51-6. doi: 10.1007/s11897-011-0075-3.

The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response?

Author information

1
UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA. jbradfield@mednet.ucla.edu

Abstract

The role of cardiac resynchronization therapy in mild heart failure has become a focus of attention with the publication of recent clinical trials. We present a review of the data supporting implantation of cardiac resynchronization devices in early stage heart failure. In addition, we present evidence that may suggest patients are often implanted too late for clinical benefit, potentially contributing to the relatively high nonresponder rate seen in randomized trials and clinical practice.

PMID:
22135184
DOI:
10.1007/s11897-011-0075-3
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center